Results 161 to 170 of about 17,345 (219)

Aseptic Meningitis With Multiple Cranial Nerve Symptoms Induced by Atezolizumab for Lung Adenocarcinoma: A Case Report. [PDF]

Cureus
Mikoshiba-Takahashi S, Matsubayashi T, Masuda M, Tsukamoto K, Yamana T, Kamimura M.   +5 more
europepmc   +1 more source

Neurologic Manifestations of Long COVID Affect Adult Females More Severely Than Males. [PDF]

Ann Clin Transl Neurol
Kopinsky H, Lopez M, Miller J, Jimenez M, Liotta EM, Koralnik IJ.   +5 more
europepmc   +1 more source

Clinical Experience With Gefapixant in a Specialized Chronic Cough Clinic: Navigating the P2X3 Pathway. [PDF]

Open Respir Arch
Crespo-Lessmann A, Bustamante D, Vélez Segovia E, Palones E, Zarate Tamames B, Najas Sales V, Garin Escrivá N.   +6 more
europepmc   +1 more source

Analysis of drug-induced adverse reactions affecting appetite and taste using the Japanese Adverse Drug Event Report Database. [PDF]

BMC Res Notes
Maese M, Kondo S, Sakatsume Y, Takagi M, Yokoyama Y, Iwata H, Kobayashi N, Yamaura K.   +7 more
europepmc   +1 more source

Efficacy and Safety of Nirmatrelvir/Ritonavir and Molnupiravir in Non-Hospitalized Patients with COVID-19: A Single-Center Retrospective Study. [PDF]

Medicina (Kaunas)
Pete M, Lendak D, Kovačević N, Pastornački A, Milovac M, Petrić V.   +5 more
europepmc   +1 more source

Real-World Evaluation of Talquetamab for the Treatment of Relapsed/Refractory Multiple Myeloma (RRMM): An International Myeloma Working Group Immunotherapy Registry Real-World Analysis. [PDF]

Am J Hematol
Janakiram M, Tan CR, Mian H, Huang CY, Popat R, Martínez-Lopez J, Kastritis E, Chng WJ, Kapoor P, Dave M, Bal S, Garderet L, Corraes AMS, Riedhammer C, Steinbrunn T, Corona M, Nagarajan C, Einsele H, Martin T, Krishnan A, Lin Y.   +20 more
europepmc   +1 more source

Dysgeusia-Driven Nutritional Decline in Cirrhosis: A Case of Autoimmune Hepatitis and Primary Biliary Cholangitis. [PDF]

Cureus
Rahming N, Corcho S, Olowe O, Falls L, Manikkavelu MK, Tiesenga F.   +5 more
europepmc   +1 more source

Post Hoc Subgroup Analyses of the Efficacy and Safety of Zavegepant for the Acute Treatment of Migraine According to Baseline Triptan Experience. [PDF]

J Pain Res
Pavlovic JM, Lipton RB, Joshi S, Fountaine R, Mosher LO.   +4 more
europepmc   +1 more source